 |
|
Ki67 Antibody Staining Protocol for Immunohistochemistry
Description: The assessment of cell proliferation by the detection of Ki67 antigen in neoplastic cell populations has been shown to be of prognostic value. The polyclonal antibody (NCL-Ki67p) labels Ki67 antigen in the granular components of the nucleolus during late G1, S, G2 and M phases. There is a strong correlation between low or high Ki67 index and low or high grade histopathology of neoplasms.
Primary Antibody
|
Name: Ki67 Antibody |
|
Clone: Rabbit anti-Human |
|
Supplier: Novocastra |
|
Catalog Number: NCL-Ki67-P |
|
Dilution: 1:3000 using IHC-TekTM Antibody Diluent (Cat# IW-1000 or IW-1001) to reduce background and unspecific staining and serum blocking step is NOT needed. |
|
Incubation Time/Temp: 60 min/room temperature |
Antigen Retrieval
| Device: IHC-TekTM Epitope Retrieval Steamer Set (Cat# IW-1102) |
| Buffer/pH value: IHC-TekTM Epitope Retrieval Solution (Cat# IW-1100) |
| Heat/Cool Temperature: 95-100 ºC/room temperature |
| Heat/Cool Time: 20 minutes/20 minutes |
Detection Methods
| Standard Method: ABC Method or LSAB Method |
| Enhanced Method: Polymeric Methods |
Chromogen Substrate
| Reagent: DAB |
| Incubation Time/Temperature: 1-3 minutes/room temperature |
Counterstain
| Reagent: Mayer's Hematoxylin |
| Staining Time: 30 seconds |
Results:
| Staining Pattern: Nuclear |
| Images: Search image |
Additional Information:
| Tissue Type: Tonsil, thymus, stomach, small intestine, colon, skin, oral mucosa and breast carcinoma, bone marrow, testis, and uterus. |
| Fixation: Formalin fixed paraffin sections |
| Positive Control: Spleen, Tonsil, breast carcinomas, GI tract. |
| Negative Control: Omit primary antibody, isotype control, absorption control |
| Blocking: 2-5% normal serum to reduce unspecific background staining; 0.5-3% H2O2 to block endogenous peroxidase activity; avidin/biotin to block endogenous biotin activity if necessary |
References: